Medicare Enrolled

Dr. Aaron Perlmutter, M.D.

Infectious Disease · Beverly Hills, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
8641 WILSHIRE BLVD, Beverly Hills, CA 90211
3106570367
In practice since 2006 (19 years)
NPI: 1114952496 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Perlmutter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Perlmutter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Perlmutter

Dr. Aaron Perlmutter is an infectious disease specialist in Beverly Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Perlmutter performed 24,222 Medicare services across 744 unique beneficiaries.

Between the years covered by Open Payments, Dr. Perlmutter received a total of $16,193 from 45 pharmaceutical and/or device companies across 542 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Perlmutter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 1% volume in CA $16,193 industry payments

Medicare Practice Summary

Medicare Utilization ↗
24,222
Medicare services
Top 1% in CA for infectious disease
744
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,275 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Testosterone injection
An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams.
19,600 $0 $0
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
3,274 $100 $200
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
480 $104 $300
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
346 $145 $450
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
324 $177 $600
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
175 $12 $50
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
23 $154 $400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,193
Total received (2018-2024)
Avg $2,313/year across 7 years
Top 12% in CA for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
542
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,277 (63.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,717 (35.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$199 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,581
2023
$1,281
2022
$1,338
2021
$1,005
2020
$1,447
2019
$4,235
2018
$5,307

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ViiV Healthcare Company
$1,005
Gilead Sciences, Inc.
$131
Merck Sharp & Dohme LLC
$82
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$75
EMD Serono, Inc.
$72
Novo Nordisk Inc
$52
Verity Pharmaceuticals Inc.
$31
Alnylam Pharmaceuticals Inc.
$27
Bayer Healthcare Pharmaceuticals Inc.
$27
Takeda Pharmaceuticals U.S.A., Inc.
$27
Lilly USA, LLC
$23
Kestra Medical Technology Services, Inc.
$16
Itamar Medical Inc
$14
Top 3 companies account for 77.0% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$6,176
ViiV Healthcare Company
$4,364
EMD Serono, Inc.
$825
Janssen Biotech, Inc.
$600
Novo Nordisk Inc
$403
Napo Pharmaceuticals Inc
$402
Takeda Pharmaceuticals U.S.A., Inc.
$345
Amgen Inc.
$313
Merck Sharp & Dohme Corporation
$294
Janssen Products, LP
$292
AbbVie Inc.
$216
Lilly USA, LLC
$202
Theratechnologies Inc.
$202
Antares Pharma, Inc.
$175
AbbVie, Inc.
$173
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$154
Neos Therapeutics, LP
$105
Alnylam Pharmaceuticals Inc.
$84
Merck Sharp & Dohme LLC
$82
Melinta Therapeutics, Inc.
$74
Janssen Pharmaceuticals, Inc
$62
Kowa Pharmaceuticals America, Inc.
$52
Novartis Pharmaceuticals Corporation
$46
Supernus Pharmaceuticals, Inc.
$45
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$39
Amarin Pharma Inc.
$37
Verity Pharmaceuticals Inc.
$31
INSYS Therapeutics Inc
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Paratek Pharmaceuticals, Inc.
$29
Bayer Healthcare Pharmaceuticals Inc.
$27
Kiniksa Pharmaceuticals, Ltd.
$25
Tris Pharma Inc
$24
Melinta Therapeutics, LLC
$24
Bayer HealthCare Pharmaceuticals Inc.
$24
Concordia Pharmaceuticals Inc.
$24
PFIZER INC.
$22
Shionogi Inc
$22
QOL Medical, LLC
$21
Boston Scientific Corporation
$20
Nabriva Therapeutics, plc
$20
ARBOR PHARMACEUTICALS, INC.
$20
Kestra Medical Technology Services, Inc.
$16
IDORSIA PHARMACEUTICALS US INC
$15
Itamar Medical Inc
$14
Top 3 companies account for 70.2% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · APRETUDE · Adzenys XR-ODT · Assure WCD · Biktarvy · CABENUVA · COLOGUARD · CREON · Corlanor · Creon · DELSTRIGO · DIFICID · DONNATAL · DOVATO · Dyanavel XR · EGRIFTA · ENTRESTO · ENTYVIO · Edarbi · Entyvio · HUMIRA · Humira · ISENTRESS · JARDIANCE · JULUCA · Kerendia · Kimyrsa · LEQVIO · LINZESS · LUCEMYRA · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MAVYRET · MOTEGRITY · MOUNJARO · Mavyret · Mytesi · NOCDURNA · NUZYRA · OTREXUP · Orbactiv · Otrexup · Ozempic · PIFELTRO · PREZCOBIX · PREZISTA · QELBREE · QUVIVIQ · RUKOBIA · Repatha · Rybelsus · SEROSTIM · STELARA · SUCRAID · SYMTUZA · SYNDROS · Saxenda · Serostim · Symproic · Symtuza · TRINTELLIX · TRIUMEQ · TROGARZO · TRULICITY · Tlando · Trintellix · Truvada · VERQUVO · VYVANSE · Vabomere · Vascepa · Victoza · Vyvanse · WatchPATONE · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xenleta · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (64%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an infectious disease specialist in Beverly Hills?
Compare infectious diseases in the Beverly Hills area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases within 10 mi
275
Per 100K population
2.8
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Perlmutter is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 12% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Perlmutter experienced with testosterone injection?
Based on Medicare claims data, Dr. Perlmutter performed 19,600 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Perlmutter receive payments from pharmaceutical companies?
Yes. Dr. Perlmutter received a total of $16,193 from 45 companies across 542 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Perlmutter's costs compare to other infectious diseases in Beverly Hills?
Dr. Perlmutter's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Perlmutter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →